Random Basketball Thoughts - 4/3/18 by Muhammad Amir Ayub

1. The Cavs have not improved after their blockbuster blow up mid-season trade. We can give them time, but will that (and Kevin Love's return) fix things before the playoffs? They just lost again to a mid tier team in the Nuggets, and are barely beating bottom dwellers. LeBron, as the best player in the league, just can't do it all.

2. Lonzo Ball is ballin. He's setting the tone, defending as usual, getting a high number of rebounds (as a PG) and scoring as needed. And the Lakers (sans Ingram) just won against the Spurs (albeit they're also missing a few important stars, but still, it's the Spurs). The Lakers did not make a mistake with him as the No 2 pick (where's Fultz anyone?).

3. It's all setting up to become an interesting end to the regular season. The West is as tight as ever. The East is also interesting as LeBron's team continues its free-fall in a weak division. Just try to close your eyes to the teams intentionally losing among the bottom-dwellers.

Sugammadex as Reversal Agent for Neuromuscular Blockade Effective in Obese Patients by Muhammad Amir Ayub

In the video presentation, Ms. Spradling explained that even when monitoring and anesthesia techniques were standardized, there were no clinical differences among obese, morbidly obese and super obese patients in the time required for reversal of rocuronium-induced neuromuscular blockade with sugammadex administered as a moderate or deep block. Furthermore, there was no significant correlation between BMI and time to reversal.

More and more proof that the rocuronium-sugammadex is right up there as one of the ultimate anesthesia combos of the modern era.